", "sentences": [], "annotations": [], "relations": []}, {"offset": 5960, "infons": {"section_type": "METHODS", "type": "title_1"}, "text": "Materials and methods", "sentences": [], "annotations": [], "relations": []}, {"offset": 5982, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Study participants", "sentences": [], "annotations": [], "relations": []}, {"offset": 6001, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Patients (age range 45-80 years, median age 67 years, 64 males and 42 females) undergoing surgery for colorectal cancer at Ninewells Hospital, Dundee or Perth Royal Infirmary were invited to participate in the study. All patients were Caucasian, had pre-operative pathological confirmation of diagnosis (ICD-9 classification 153.0-153.9, 154.0-154.1) and had no history of previous cancer, inflammatory bowel disease, ulcerative colitis or diverticular disease. Patient details have been described previously. The study was approved by the Tayside Committee on Medical Research Ethics and written informed consent was obtained from all study participants.", "sentences": [], "annotations": [], "relations": []}, {"offset": 6663, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "DNA preparation", "sentences": [], "annotations": [], "relations": []}, {"offset": 6679, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Primary colorectal tumour resection specimens were brought fresh from theatre to pathology and tumours selected by an experienced pathologist and stored in liquid nitrogen before analysis. Genomic DNA for mutation analysis was extracted using the Wizard Genomic DNA Purification Kit (Promega, Southampton, UK) according to the manufacturer's instructions. All study participants provided a 10 ml venous blood sample, which was stored in EDTA blood containers at -20 C. Genomic DNA was extracted from 200 mul of whole blood, using a QIAamp 96 spin blood kit (Qiagen, Crawley, West Sussex, UK) according to the manufacturer's instructions.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7324, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "K-Ras and B-Raf mutation detection", "sentences": [], "annotations": [], "relations": []}, {"offset": 7359, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Methods for K-Ras and B-Raf mutation detection and restriction fragment length polymorphism (RFLP) analysis of mutation frequencies are given in Appendix A.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7516, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Cell culture and transfection", "sentences": [], "annotations": [], "relations": []}, {"offset": 7546, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The mouse embryonic fibroblast cell line NIH3T3 was obtained from Cancer Research UK cell services. NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf serum unless otherwise stated, at 37 C in 5% CO2. Cells were transfected using Lipofectamine (Invitrogen, Paisley, UK) according to the manufacturer's instructions.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7913, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Mammalian expression plasmids", "sentences": [], "annotations": [], "relations": []}, {"offset": 7943, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The pEF.6 plink and pEFHA wt K-Ras plasmids were kind gifts from Professor Richard Marais (Institute of Cancer Research, London, UK). Site-directed mutagenesis (SDM) was carried out on the pEFHA wt K-Ras plasmid using the QuikChange II SDM kit (Agilent, South Queensferry, Edinburgh, UK) according to the manufacturer's instructions to generate the following K-Ras mutations: G12V, G12D, G13D, Q61H, L19F, K117N, A146T and R164Q, using the oligonucleotide primers described in Table 1.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8429, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "K-Ras foci formation assays", "sentences": [], "annotations": [], "relations": []}, {"offset": 8457, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "NIH3T3 cells were seeded at 2.5 x 105 cells in 35 mm culture dishes and allowed to adhere overnight before transfection with 250 ng of either pEF.6, pEFHA (wt K-Ras) or plasmids containing one of the following K-Ras mutants: G12V, G12D, G13D, Q61H, L19F, K117N, A146T or R164Q. After 24 h, cells were trypsinised and split (1 : 3) between two 10 cm3 plates and grown in DMEM containing 5% calf serum for 21 days, then fixed with methanol and stained with 0.5% (w/v) crystal violet. Foci greater then 5 mm were counted manually.